Position in AMGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,104,330
+$678,049 QoQ
Shares Held
11,665
+11.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $24,166,889 across 16 Drug Manufacturers - General names. AMGN ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,429 | $5,971,424 | |
| 2 | AMGN |
Amgen Inc
This page
|
11,665 | $4,104,330 | |
| 3 | LLY |
ELI LILLY & Co
|
3,526 | $3,243,109 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,309 | $2,924,129 | |
| 5 | ABBV |
AbbVie Inc.
|
13,037 | $2,835,417 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,974 | $2,783,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,168 | $980,589 | |
| 8 | PFE |
Pfizer Inc
|
32,618 | $915,913 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,104,330 | 11,665 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,426,281 | 10,468 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,987,816 | 7,044 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,500,195 | 5,373 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,667,104 | 5,351 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,410,844 | 5,413 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,441,245 | 4,473 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,409,461 | 4,511 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,224,850 | 4,308 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,198,739 | 4,162 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,100,303 | 4,094 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $893,408 | 4,024 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $967,725 | 4,003 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,106,502 | 4,213 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $838,488 | 3,720 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $726,493 | 2,986 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $725,701 | 3,001 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $527,159 | 2,479 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $438,993 | 1,801 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $340,372 | 1,368 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $275,674 | 1,199 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $304,737 | 1,199 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $264,634 | 1,122 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $227,463 | 1,122 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||